Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 7—July 2020
Synopsis

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia

Yu-Chin Chen1, Wei-Yun Hsu1, and Tu-Hsuan Chang1Comments to Author 
Author affiliations: Chi-Mei Medical Center, Chiali, Tainan, Taiwan (Y.-C. Chen); Chi-Mei Medical Center, Tainan, Taiwan (W.-Y. Hsu, T.-H. Chang)

Main Article

Figure 6

The duration difference (days) of antibiotic use between MRMP and MSMP infections in meta-analysis of MRMP infections in pediatric community-acquired pneumonia. MD, mean difference; MRMP, macrolide-resistant Mycoplasma pneumoniae; MSMP, macrolide-sensitive Mycoplasma pneumoniae.

Figure 6. The duration difference (days) of antibiotic use between MRMP and MSMP infections in meta-analysis of MRMP infections in pediatric community-acquired pneumonia. MD, mean difference; MRMP, macrolide-resistant Mycoplasma pneumoniae; MSMP, macrolide-sensitive Mycoplasma pneumoniae.

Main Article

1All authors contributed equally to this article.

Page created: April 03, 2020
Page updated: June 18, 2020
Page reviewed: June 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external